184 related articles for article (PubMed ID: 32728184)
1. RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.
Gassner FJ; Zaborsky N; Buchumenski I; Levanon EY; Gatterbauer M; Schubert M; Rauscher S; Hebenstreit D; Nadeu F; Campo E; Egle A; Greil R; Geisberger R
Leukemia; 2021 Apr; 35(4):1053-1063. PubMed ID: 32728184
[TBL] [Abstract][Full Text] [Related]
2. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain.
Liscovitch N; Bazak L; Levanon EY; Chechik G
RNA Biol; 2014; 11(11):1447-56. PubMed ID: 25692240
[TBL] [Abstract][Full Text] [Related]
3. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR).
Solomon O; Oren S; Safran M; Deshet-Unger N; Akiva P; Jacob-Hirsch J; Cesarkas K; Kabesa R; Amariglio N; Unger R; Rechavi G; Eyal E
RNA; 2013 May; 19(5):591-604. PubMed ID: 23474544
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
[TBL] [Abstract][Full Text] [Related]
5. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
7. All I's on the RADAR: role of ADAR in gene regulation.
Shevchenko G; Morris KV
FEBS Lett; 2018 Sep; 592(17):2860-2873. PubMed ID: 29770436
[TBL] [Abstract][Full Text] [Related]
8. Altered adenosine-to-inosine RNA editing in human cancer.
Paz N; Levanon EY; Amariglio N; Heimberger AB; Ram Z; Constantini S; Barbash ZS; Adamsky K; Safran M; Hirschberg A; Krupsky M; Ben-Dov I; Cazacu S; Mikkelsen T; Brodie C; Eisenberg E; Rechavi G
Genome Res; 2007 Nov; 17(11):1586-95. PubMed ID: 17908822
[TBL] [Abstract][Full Text] [Related]
9. ALU A-to-I RNA Editing: Millions of Sites and Many Open Questions.
Schaffer AA; Levanon EY
Methods Mol Biol; 2021; 2181():149-162. PubMed ID: 32729079
[TBL] [Abstract][Full Text] [Related]
10. Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.
Forni D; Mozzi A; Pontremoli C; Vertemara J; Pozzoli U; Biasin M; Bresolin N; Clerici M; Cagliani R; Sironi M
RNA Biol; 2015; 12(2):149-61. PubMed ID: 25826567
[TBL] [Abstract][Full Text] [Related]
11. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
12. Genetic lesions in chronic lymphocytic leukemia: clinical implications.
Montserrat E; Moreno C
Curr Opin Oncol; 2009 Nov; 21(6):609-14. PubMed ID: 19713841
[TBL] [Abstract][Full Text] [Related]
13. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Wang C; Zou J; Ma X; Wang E; Peng G
Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449
[TBL] [Abstract][Full Text] [Related]
15. Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
Maura F; Cutrona G; Mosca L; Matis S; Lionetti M; Fabris S; Agnelli L; Colombo M; Massucco C; Ferracin M; Zagatti B; Reverberi D; Gentile M; Recchia AG; Bossio S; Rossi D; Gaidano G; Molica S; Cortelezzi A; Di Raimondo F; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
Leuk Lymphoma; 2015; 56(11):3150-8. PubMed ID: 25860243
[TBL] [Abstract][Full Text] [Related]
16. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
17. The Epitranscriptome and Innate Immunity.
O'Connell MA; Mannion NM; Keegan LP
PLoS Genet; 2015 Dec; 11(12):e1005687. PubMed ID: 26658668
[TBL] [Abstract][Full Text] [Related]
18. Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.
Vlachogiannis NI; Gatsiou A; Silvestris DA; Stamatelopoulos K; Tektonidou MG; Gallo A; Sfikakis PP; Stellos K
J Autoimmun; 2020 Jan; 106():102329. PubMed ID: 31493964
[TBL] [Abstract][Full Text] [Related]
19. RNA editing signature during myeloid leukemia cell differentiation.
Rossetti C; Picardi E; Ye M; Camilli G; D'Erchia AM; Cucina L; Locatelli F; Fianchi L; Teofili L; Pesole G; Gallo A; Sorrentino R
Leukemia; 2017 Dec; 31(12):2824-2832. PubMed ID: 28484266
[TBL] [Abstract][Full Text] [Related]
20. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
